Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cathepsin S inhibition combines control of systemic and peripheral pathomechanisms of autoimmune tissue injury
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-30
DOI
10.1038/s41598-017-01894-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma levels of adipokines in systemic lupus erythematosus patients
- (2016) Tian-Ping Zhang et al. CYTOKINE
- Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications
- (2015) S. Kumar VR et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN
- (2015) S. V. R. Kumar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis
- (2014) J. Hogan et al. Clinical Journal of the American Society of Nephrology
- Cathepsin S Causes Inflammatory PainviaBiased Agonism of PAR2and TRPV4
- (2014) Peishen Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cathepsin S Signals via PAR2 and Generates a Novel Tethered Ligand Receptor Agonist
- (2014) Sarina B. Elmariah et al. PLoS One
- Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis
- (2014) T Ruge et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming
- (2013) Khader Valli Rupanagudi et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibiting cathepsin S to treat SLE and lupus nephritis
- (2013) Nicholas J. Bernard Nature Reviews Rheumatology
- Cathepsin S as a biomarker: where are we now and what are the future challenges?
- (2012) Johan Ärnlöv Biomarkers in Medicine
- Quantitative Expression of C-Type Lectin Receptors in Humans and Mice
- (2012) Maciej Lech et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cathepsin S dominates autoantigen processing in human thymic dendritic cells
- (2012) Christina Stoeckle et al. JOURNAL OF AUTOIMMUNITY
- Association Between Serum Cathepsin S and Mortality in Older Adults
- (2011) Elisabeth Jobs et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity
- (2011) Mark Baugh et al. JOURNAL OF AUTOIMMUNITY
- A Unique Hybrid Renal Mononuclear Phagocyte Activation Phenotype in Murine Systemic Lupus Erythematosus Nephritis
- (2011) R. Bethunaickan et al. JOURNAL OF IMMUNOLOGY
- IRF4 Deficiency Abrogates Lupus Nephritis Despite Enhancing Systemic Cytokine Production
- (2011) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
- (2011) Oliver Gross et al. KIDNEY INTERNATIONAL
- Systemic Lupus Erythematosus and the Neutrophil
- (2011) Xavier Bosch NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the Recruitment of Monocytes and Macrophages in Renal Disease
- (2010) Volker Vielhauer et al. SEMINARS IN NEPHROLOGY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating Toll-like receptor 2 at the glomerular filtration barrier
- (2009) Rahul D. Pawar et al. IMMUNOLOGY
- Adverse events and efficacy of TNF- blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients
- (2009) M. Aringer et al. RHEUMATOLOGY
- The role of innate immunity in autoimmune tissue injury
- (2008) Ramanjaneyulu Allam et al. CURRENT OPINION IN RHEUMATOLOGY
- Viral 5′-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses
- (2008) Ramanjaneyulu Allam et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cysteine cathepsin S as an immunomodulatory target: present and future trends
- (2008) Suman Gupta et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started